Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,639 public trials 556 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Recruiting

Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis

NCT06569147

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Yale University New Haven, Connecticut, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Tufts Medical Center Boston, Massachusetts, United States
View Trial Details
Recruiting

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

NCT06292780

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • City of Hope Duarte, California, United States
  • Colorado Blood Cancer Institute/SCRI Denver, Colorado, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View all 21 locations
View Trial Details
Recruiting

DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

NCT07440290

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +78 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Bristol Royal Hospital for Children Bristol, United Kingdom
View all 27 locations
View Trial Details
Recruiting

A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma

NCT07105059

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

NCT05850234

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
View all 36 locations
View Trial Details
Recruiting

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

NCT07409246

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • City of Hope National Medical Center /ID# 280273 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 279067 Irvine, California, United States
  • Colorado Blood Cancer Institute /ID# 280275 Denver, Colorado, United States
  • START Midwest /ID# 279035 Grand Rapids, Michigan, United States
View Trial Details

Related conditions